Dynacare Laboratories

Similar documents
MEMORANDUM. Carol Ghere, MT (ASCP) SI, Compliance Officer CPT4 Code Changes from American Medical Association (AMA)

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

Forensic Toxicology Scope of Testing and Detection Limits

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

MLABS DEPARTMENT OF PATHOLOGY ATTN: IMPORTANT TEST INFORMATION CPT UPDATES 2015 REVISED

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

Urine Drug Testing Methods 3-5

Physician s Reference for Urine and Blood Drug Testing and Interpretation

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

Drug Adherence Assessment Report

Your Results are Our Priority.

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

Quest Diagnostics Drug Testing Index Full Year 2015 Tables

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

2015 Annual Physician Notice

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

1. Amphetamine (Adderall, desoxyn, Dexedrine,dextrostat, spancap, oxydess II)

The Drug Testing Process. Employer or Practice

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

Laboratory Service Report

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Disclosures. Get Your Specimens in Order:

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc.

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

MEDICAL POLICY Drug Testing

New Test Announcements

Drug Screening. Separating Facts from Myths

Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

Conflict of Interest Disclosure

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Urine Opioid Dependency Panel (UODP) 1

10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

nextgen precision Test Report

MEDICAL POLICY Drug Testing

Pain Medication Management Program Monitors Patient Compliance

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

SUPPLEMENTARY MATERIALS. Appendix 1. Definition of Suicidal Behavior Using ICD-9 Diagnostic Codes.

DrugConfirm Advanced Urine Dip Cards.

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)

Toxicology Practice and Procedure Handbook

PROGRAM General Information

Testing for Controlled Substances

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

Drug Testing Basics. by Erowid

Rapid Alcohol Screening Devices. p19

Product Catalog. May We are Toxicology. Tel Toll Free Fax

DRUGS OF ABUSE

INTERPATH LABORATORY, INC. TEST UPDATES

May Revised Urine Drug Screen Test Menu Effective mid-june Lauren Anthony, MD, MT(ASCP) SBB Medical Director, Allina Health Laboratory

80305, 80306, 80307,G0480, G0481, G0482, G0483, G0659

Pinellas County Forensic Laboratory. Annual Report 2006

Contract No. 952-M1 Collection Service Requirements Texas Department of Criminal Justice (TDCJ)

MEDICAL POLICY No R2 DRUG TESTING

Agilent Clinical LC/MS: Review of Established LC-MS QQQ Clinical Research Applications. dr. Jan Srbek, HPST. Page 1

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS

PARTICIPANT GENERAL INFORMATION


Product Catalog. February We are Toxicology. Tel Toll Free Fax

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.

POINT OF CARE TESTING

DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide.

Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey

Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients

Test Bulletin. Specimen Type. Preferred Volume. PCA3 PCA3TM Urine 2.5 ml KIT Frozen. URCTFR Urine 2.5 ml Urine Refrigerated

Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements.

European Guidelines for Workplace Drug Testing in UrineandOral fluid

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent?

2013 Clinical drug and alcohol testing solutions. Product Catalog. CLIA-waived point of care test devices

2017 Drug Screen Tests

Drugs of Abuse I Serum

European Guidelines for Workplace Drug Testing in Blood and Blood Spots

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)

Clinical Drug Screening and/or Drug Testing

Procedure for Toxicology Analysis Version 4 Toxicology Unit Effective Date: 05/10/2013. Toxicology Analysis

Schedule of Accreditation

Pain Medication Management Program Supports Patient Outcomes and Adherence

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

ONLINE DAT II Results matter.

Drug Screening: Things You Need to Know

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies

Medications and Children Disorders

ToxCup Drug Screen Cup Step-by Step Instructions

Validation of an Automated Method to Remove

DOF. Scheme Description. Drugs in Oral Fluid Scheme

Powering Efficient Behavioral Health Care Services

Transcription:

Dynacare Laboratories Affiliated with Froedtert & the Medical College of Wisconsin January 2015 2015 CPT Code Updates Dear Client: The American Medical Association (AMA) publishes the Current Procedural Terminology (CPT) Coding Manual on an annual basis. For 2015, the AMA made several changes to the Pathology and Laboratory 80000 code section of the CPT manual, including 107 new codes added, 47 deleted codes, and 32 revised codes. We have highlighted some important changes below. Toxicology Changes: The AMA added a new section entitled Drug Assay that contains 63 new CPT codes (80300-80377). The codes in the current 2014 Drug Testing section (80100-80104) have been deleted. The 2015 revised codes allow for additional specificity in differentiating the types of specimen being tested. The drug procedures are now divided into the following subsections: Drug Assay Therapeutic Drug Assays Chemistry Under Drug Assay, presumptive procedures are used to identify possible use or non-use of a drug or drug class and may be followed by a definitive test to specifically identify drugs or metabolites. Definitive drug testing may be quantitative or qualitative and does not require prior presumptive testing. Therapeutic Drug Assays are performed to monitor clinical response to a known, prescribed medication. Microbiology Changes: Current CPT code 87621 for Human papillomavirus (HPV) has been changed to 87624. This code covers testing for HPV High Risk genotypes. Pathology Changes: In the Immunohistochemistry (IHC) and In-situ Hybridization (ISH) code descriptors, the unit of service (UOS) has been changed to per specimen rather than per block for each primary code. Each primary code will also read initial single antibody procedure for IHC and initial single probe stain procedure for ISH. Dynacare Laboratories (12/2014) Page 1

Additional 2015 changes include the following additions: New IHC add-on code for each additional antibody stain procedure New ISH add-on code for each additional single-probe procedure New IHC and ISH codes for reporting of multiplex probe stain procedures This summary of CPT code changes provides general guidelines based on the AMA s 2015 CPT Code Manual. Always confirm with the applicable payer to insure appropriate CPT code(s) are used in each case, as the billing party is responsible for its CPT coding. We hope you find this information beneficial to your office staff. Please contact our Client Services department should you have questions. Thank you for selecting Dynacare Laboratories as your laboratory services provider. Sincerely, Dynacare Laboratories Dynacare Laboratories (12/2014) Page 2

Attachment I 2015 CPTs in BOLD The CPT Codes listed are in accordance with the current edition of Current Procedural Terminology, a publication of the American Medical Association. CPT codes are provided for the convenience of our clients; however, correct coding often varies from one carrier to another. Consequently, the codes presented here are intended as general guidelines and should not be used without confirming with the applicable payor that their use is appropriate in each case. Molecular Pathology Changes Test number 489160 Prostate Cancer Gene 3 (PCA3) 81479 81313 Immunohistochemistry (IHC) changes Initial single IHC antibody stain procedure, per specimen 88342 88342 Each additional IHC antibody stain on a single specimen 88342 88341 Each IHC multiplex antibody stain procedure (ie, multiplex antibody stain 88342, procedure) 88343 88344* Morphometric analysis, tumor immunohistochemistry, quantitative or semiquantitative, each single antibody stain, manual, per specimen 88360 88360 Morphometric analysis, tumor immunohistochemistry, quantitative or semiquantitative, each single antibody stain, computer-assisted technology, per specimen 88361 88361 *The number of units billed is dependent on the specific multiplex test that is performed. In Situ Hybridization (ISH) changes In situ hybridization, initial single probe, per specimen 88365 88365 Each additional single probe stain procedure 88365 88364 Each multiplex probe stain procedure, per specimen (ie, multiplex probe stain procedure) 88365 88366* Morphometric analysis, in situ hybridization, quantitative or semiquantitative, initial single probe stain procedure, manual, per 88368 88368 specimen Each additional single probe stain procedure, per specimen 88368 88369 Each separately identifiable probe applied to the same specimen (ie, multiplex probe stain procedure) 88368 88377* *The number of units billed is dependent on the specific multiplex test that is performed. Dynacare Laboratories (12/2014) Page 3

Test number 5600005 5600089 5600095 3509949 Microbiology Human Papillomavirus (HPV) high-risk with 16/18 genotype 87621 87624 Toxicology Test number 8000540 Acetaminophen, Quantitative 80301 80302 8000950 Quinidine 80194 80194 1000909 Salicylate 80101 80329 8001335 Valproic Acid, Free 80164 80165 8000649 Amphetamines, Urine 80101 80301 8002080 Barbiturates, Urine 80101 80301 8000549 Barbiturate Rapid Screen 80100 80301 8002065 Benzodiazepines, Urine 80101 80301 8000559 Benzodiazepine Rapid Screen 80100 80301 8000659 Cannabinoids, Urine 80101 80301 8000669 Cocaine/Benzoylecgonine, Urine 80101 80301 3508089 Ethanol, Urine 80101 80301 8000500 Ethanol, Serum 80101 80301 8002095 Methadone, Urine 80101 80301 8000707 Methaqualone, Urine 80101 80301 8000679 Opiates, Urine 80101 80301 8000708 Oxycodone/Oxymorphone, Urine 80101 80301 8000689 PCP, Urine 83992 80301 8002200 Propoxyphene, Urine 80101 80301 8000569 Tricyclic Rapid Screen, Serum 80101 80301 8000590 Methanol Quantitative, Serum 84600 80320 8002051 Acetone/Isopropanol, Quantitative, Serum 80101 80320 8000580 Volatile Screen, Serum 84600 80320 8000630 Ethylene Glycol, Quantitative, Serum 82693 80320 3551345 Nicotine and metabolite, Quantitative, Serum 83887 80323 8001190 Tacrolimus, FK506 80197 1500850 Cyclosporin, Parent Compound 80158 8001105 Sirolimus (Rapamycin) 80195 3555057 Everolimus 80169 8004005 Fentanyl, Quantitative, Urine 80101 80354 8004020 Oxycodone, Quantitative, Urine 80101 80365 8004010 Hydrocodone, Quantitative, Urine 80101 80361 8004015 Methadone, Quantitative, Urine 80101 80358 8004025 Tramadol, Quantitative, Urine 80101 80373 Dynacare Laboratories (12/2014) Page 4

8004030 Opiates, Quantitative, Urine 80101 80354, 80365, 80361, 80358, 80373 3508130 Alprazolam (Xanax) 80154 80346 3507512 Amiodarone 82542 80299 3507547 Amitriptyline/Nortriptyline 80152 80335 3551430 Amphetamine Confirmation Urine 82145 80324 3551440 Barbiturate Confirmation Urine 82205 80345 3551390 Benzodiazepine Confirmation Urine 80154 80346 3550907 Buprenorphine Confirmation Urine 83925 80348 3550906 Buprenorphine Urine 80101 80301 3507505 Busulfan 82491 80299 3551420 Cannabinoid Confirmation Urine 82542 80349 3508010 Carbamazepine 10-11 Epoxide 82542 80339 3507560 Chlorpromazine 84022 80342 3057570 Clomipramine 82542 80335 3507580 Clonazepam 80154 80346 3507545 Cocaine Benzoylecgonine Quant Urine 82520 80353 3507601 Cocaine Meconium 80101 80301 3551480 Cocaine Metabolite Confirmation 82520 80353 3507580 Desipramine 80160 80335 3526085 Dexamethasone Level 82542 80375 3508100 Diazepam ((Valium) 80154 80346 3508069 Diuretic Screen Urine 80100 80377 3507984 Doxepin (Sinequan) 80166 80335 3507502 Drug Investigation Urine 80100 80303 3551770 Ethyl Glucuronide Urine 80101 80302 8001200 Felbamate 82542 80339 3551545 Fentanyl Confirmation Urine 83925 80354 3551540 Fentanyl Screen and Confirmation Urine 80101 80302 3507720 Flecainide 82542 80299 8001210 Fluoxetine 82542 80332 3508277 Gold 80172 80375 3550417 Hydrocodone (Vicodin) 83925 80361 3507517 Imipramine/Desipramine 80174 80335 3507790 Lorazepam 80154 80346 3507504 MDMA (Ecstasy) Qualitative Urine 80101 80301 3551532 MDMA + Metabolites Confirmation Urine 82145 80359 3507810 Mephobarbital 82205 80345 3507815 Mephobarbital (Mebaral) 80184, 80184, 82205 80345 3507732 Methadone 83840 80358 3551470 Methadone Confirmation Urine 83840 80358 Dynacare Laboratories (12/2014) Page 5

3507840 Methsuximide 83858 80339 3507870 Morphine 83925 80361 3508015 Nicotine Metabolite Urine 80101 80302 3507547 Nortriptyline 80182 80335 3550319 Olanzapine (Zyprexa) 82542 80342 3551410 Opiate Confirmation Urine 83925 80361 3507604 Opiate Meconium 80101 80301 3507875 Oxazepam 82491 80346 3550419 Oxycodone (Percodan) 83925 80365 3551400 Oxycodone Confirmation Urine 83925 80365 3507905 Paraldehyde and Acetaldehyde 82000 82492 3507910 Pentobarbital 82205 80345 3551465 Propoxyphene Confirmation Urine 83925 80367 3507735 Risperidone (Risperal) 82542 80342 3550493 Sulfonylurea Screen 82542 80377 3507603 THC Meconium 80101 80301 3507820 Thioridazine (Mellaril) and Mesoridazine 84022 80342 3508040 Trazodone 82542 80338 3508060 Trilafon 84022 80342 3508110 Warfarin 82471 80375 Dynacare Laboratories (12/2014) Page 6